Home > Pevonedistat

molecules of the month

<< Back to May

Pevonedistat

Recent Publication

intravenous NEDD8-activating enzyme inhibitor

Ph. III candidate for oncology

from HTS and optimization

Drug Metab. Dispos.

Takeda, Lexington, MA

Context. Pevonedistat (Takeda) is a first-in-class intravenous or subcutaneous NEDD8-activating enzyme (NAE) inhibitor being developed for leukemia and advanced solid tumors. NAE is a pivotal regulator of the NEDD8…

this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.

LEARN MORE

Pevonedistat

this content is exclusive to Premium members

this content is exclusive to
Premium members